Fueled up on more Chevron
Buffett increased his investment in integrated energy giant Chevron by 33%, adding more than 9.5 million shares during the quarter. Berkshire’s total stake in the company is now valued at roughly $4.5 billion.
Recently, Chevron shares blasted off to hit a new all-time high, just shy of $140. But despite the recent run, the shares continue to be modestly valued at just 17 times trailing earnings. With a 4.2% dividend yield and secular trends in its favor, it's not a big mystery as to why Buffett added to his stake.
Oil prices have been rocketing higher of late, and Buffett was one of many to get in well before prices had a chance to take off. With oil prices eclipsing $100 per barrel, Chevron certainly has the wind at its back.
Chevron's latest quarter revealed a lot to be excited about. Most notably, Chevron's capital expenditures have been on the retreat, while higher oil prices propelled the firm into profitability.
Though oil prices are volatile and difficult to predict, Chevron seems to have the financial muscle to absorb the shock of any near-term pullback in the price of oil.
Big energy has momentum and value by its side. Buffett followers should take notice of the man's one-third top-up.
Invest in real estate without the headache of being a landlord
Imagine owning a portfolio of thousands of well-managed single family rentals or a collection of cutting-edge industrial warehouses. You can now gain access to a $1B portfolio of income-producing real estate assets designed to deliver long-term growth from the comforts of your couch.
The best part? You don’t have to be a millionaire and can start investing in minutes.
Learn MoreBuffett bought Activision Blizzard before Microsoft did
Another intriguing move by Buffett was his stake in Activision Blizzard — valued at around $975 million as of the end of 2021 — before Microsoft announced its plans to buy it for $69 billion.
Indeed, the timing of Buffett's investment raised some eyebrows in the financial media. Berkshire had to clear the air, dismissing any possession of insider information held prior to the transaction.
Buffett is famous for his value investing approach. Activision was a beaten-down video-game giant that was dragged lower over reputational concerns — all issues that were likely to be sorted out with time. As a long-term investor, Buffett is more than willing to take a chance on high-quality businesses that are being beaten down by near-term noise.
For now, regulators will have many looks at the potential deal.
Should the deal go through, Activision shareholders can expect $95 per share — another 17% increase from current levels. Activision's management structure can also be expected to see further change once it shifts over the hands of Microsoft.
Buffett sold Visa and Mastercard; bought shares of Brazilian fintech
Buffett further reduced his stakes in Visa and Mastercard in the fourth quarter by 13% and 7%, respectively.
The valuation on the pair of stocks had become stretched through most of 2021.
Even after recent turbulence, shares of Visa trade at over 35 times trailing earnings. Mastercard trades at over 40 times earnings. That's particularly lofty, especially given the intensifying competition from many up-and-coming disruptors in the payments space.
Perhaps it’s no surprise that Berkshire took a $1 billion stake in tech-savvy Brazillian neobank Nu Holdings during the quarter, as well.
To be sure, Buffett is known for being somewhat averse to tech stocks. Ted Weschler and Todd Combs, Buffett’s trusted investment lieutenants, might actually be the ones positioning Berkshire for the fintech wave.
Maximize Your Savings
Discover the best option for your financial future. Whether you’re looking for higher returns or easy access to your cash, compare the benefits of CDs and savings accounts to find the right fit for your goals.
Learn MoreBuffett completely reverses course on drug stocks
Buffett also drastically cut stakes in several biotech stocks that he had purchased relatively recently.
In Q4, Berkshire slashed its investment in both Bristol Myers Squibb and AbbVie by more than 75%. Moreover, it completely exited its position in perennial underperformer Teva Pharmaceuticals.
Berkshire also gave up on holding company Royalty Pharma in a hurry, cutting its stake by 34% during the quarter. The position was just initiated in Q3.
More from Moneywise
- 4 Ways to Earn Big Returns in 2022 Without the Shaky Stock Market
- Jim Rogers: Next Bear Market Will Be ‘Worst in My Lifetime’ — He'll Rely on 3 Assets
- Robert Kiyosaki Says We're Already in a 'Technical Depression' — He's Using These 3 Assets for Protection
Sponsored
Follow These Steps if you Want to Retire Early
Secure your financial future with a tailored plan to maximize investments, navigate taxes, and retire comfortably.
Advisor is an online platform that can match you with a network of vetted fiduciary advisors who are evaluated based on their credentials, education, experience, and pricing. The best part? - there is no fee to find an advisor.
